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In a clinical setting, diabetic autonomic complications (cardiac, gastrointestinal, urogenital, etc.) are often handled as separate
entities. We investigated rectal sensitivity to heat, mechanical distension, and electrical stimulations in 20 patients with diabetes
and symptoms of gastroparesis, to evaluate the extent of visceral neuronal damage. Furthermore, to evaluate the relation between the
nervous structureswe examined gastric emptying and cardiac autonomic functionwith the hypothesis being an association between
these.We found that 60% of patients had delayed gastric empting. Rectal hyposensitivity was a general finding as they tolerated 67%
higher thermal, 42% more mechanical, and 33% higher electrical current intensity compared to healthy controls. In patients, most
heart rate variability parameters were reduced; they reported significantly more gastrointestinal symptoms and a reduced quality of
life in all SF-36 domains. Shortened RR interval correlated with reduced rectal temperature sensitivity, and gastric retention rate was
negatively associated with symptoms of nausea and vomiting. To conclude, in these patients with signs and symptoms of diabetic
gastroparesis, rectal sensitivity was reduced, and heart rate variability was impaired.Thus, we suggest regarding diabetic autonomic
neuropathy as a diffuse disorder. Symptoms of widespread autonomic dysfunction and sensory disorders should be expected and
treated in these patients.
1. Introduction
Gastrointestinal (GI) complaints are more common in all
types of diabetes mellitus (DM) patients compared to the
general population [1, 2]. Symptoms such as pain, bloating,
excessive fullness, vomiting and diarrhea may range from
mild and intermittent to severe and life-threatening. Treat-
ment options are limited (diet, pharmacological, and invasive
procedures) and frequently incapable of adequate symptom
relief [3]. Recent years have seen an improved understanding
of the multiple coexisting pathophysiological mechanisms
behind the symptoms. In addition to peripheral autonomic
neuropathy and affection of the sensory visceral nerves,
functional changes have also been detected in the brain net-
works encoding visceral pain [4, 5]. Mirroring this, magnetic
resonance imaging techniques have revealed altered brain
microstructure in the so-called “pain matrix” of the brain
[6, 7]. Other mechanisms include altered elasticity of the GI
wall, enterohormonal changes, anxiety/depression, exocrine
pancreatic insufficiency, bacterial imbalance, autoimmunity,
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loss of interstitial cells of Cajal, and the direct effects of
hyperglycemia on GI motility [8–10]. In line with this
complex pathophysiology, the association between upper
GI symptoms and gastric emptying is modest. Conversely,
gastric emptying rate cannot explain the range of upper GI
symptoms experienced, neither in DM patients nor in the
case of idiopathic gastroparesis [11–14].
Until now, the majority of studies in this field have
focused on diabetes complications of the upper GI tract.
Knowledge about the extent of damage to the lower GI tract is
sparse; however, in one of our recent studies we demonstrated
rectal hyposensitivity in patients suffering from diabetic
sensorimotor neuropathies [15]. A limited number of stud-
ies have examined the rectal sensitivity to distention in
diabetes patients with fecal incontinence; however, none
have employed multimodal sensory investigations with the
possibility to investigate several nerve fibres and pathways
[16, 17].
We hypothesised that DM patients with upper GI symp-
toms are hyposensitive in the distal GI tract and that visceral
sensitivity, gastric emptying rate, cardiac autonomic function,
and clinical symptoms would be associated. Thus, the main
aim of this study was to examine the rectosigmoid sensitivity
to multiple modalities (heat, mechanical distension, and
electrical stimulations) in diabetes patients with symptoms of
upper GI dysmotility. Furthermore, we aimed to characterise
these patients in terms of cardiac autonomic parameters,
gastric emptying rate, quality of life, and GI symptom scores.
2. Research Design and Methods
2.1. Subjects. Twenty diabetes patients were included
between August 2010 and October 2011 from the outpatient
clinic at Haukeland University Hospital. Inclusion criteria
were upper GI symptoms refractory to treatment, type
1 or type 2 DM, and age between 18 and 65 years. All
patients had previously undergone a gastroscopy in order to
rule out other causes of their complaints. Major exclusion
criteria were implanted gastric electrical stimulation device,
nonneuropathic pain conditions, uremia, alcohol abuse, and
unwillingness to cease analgesics or prokinetics prior to
sensory examinations. Two patients were unable to tolerate
the rectosigmoid probe, but completed the other parts of the
study. As a control group, 16 healthy volunteers without GI
complaints were recruited from the medical departments
at Bergen and Aalborg University Hospitals. Clinical chara-
cteristics of the study population are summarized in Table 1.
Oral and written consent was obtained from all participants,
and the study was approved by the local ethics committees
(Regional Etisk Komite´ Vest 2010/2562-6 and Aalborg
N-20090008).
2.2. Gastric Emptying. Prior to the experimental rectal sen-
sory assessments, all patients had their gastric emptying rates
evaluated. Twenty spherical radiopaque markers (diameter
4mm, density 1.27 g/mm3) where given together with a
standardized breakfast. The number of markers still present
in the stomach was determined by the help of fluoroscopy
Table 1: Clinical characteristics.
Variables Patients(𝑛 = 20)
Controls
(𝑛 = 16)
Age (years) 44.5 (±9.6) 44.8 (±9.3)
Gender (male/female) 5/15 5/11
Body mass index (kg/m2) 26.5 (±5.1) 24.4 (±3.4)
Diabetes duration (years) 26.5 (±9.9) —
Diabetes type (1/2) 17/3 —
HbA1c (%) 9.7 (±2.1) 5.6 (±0.2)
Smoking status
(never/past/present) 10/4/5 10/6/0
Retinopathy (%) 65 —
Known neuropathy (%) 55 —
Known cardiovascular disease
(%) 20 0
Creatinine level (IQ-range)
(𝜇mol/L)
69.0
(58.0–104.0)
72.0
(66.5–78.0)
Beta-blocker (%) 20 0
ACEI/angiotensin receptor
blocker (%) 45 6
Statin use (%) 65 6
Data are means (±SD) unless otherwise indicated.
ACEI = angiotensin converting enzyme inhibitor.
after 4, 5, and 6 hours, enabling the calculation of an average
retention rate. Gastroparesis was defined as a retention rate
>26% in males and >63% in females through the 4–6 hour
period. The method has a sensitivity of 34% and specificity
of 97% compared to scintigraphy and has been further
described and validated elsewhere [11].
2.3. Rectal Sensory Assessment. On a separate study day,
participants were instructed to fast for at least 6 hours
prior to sensory examinations. In order to avoid the effect
of glucose and insulin levels on GI sensations, both DM
patients and healthy controls underwent a euglycemic hyper-
insulinemic clamp procedure [18]. Sensory assessments were
performed upon achieving the target blood glucose of 6mM.
Participants were instructed to grade the sensations using
a modified Visual Analogue Scale (VAS). The scale is well
known, validated, and has been employed in several studies
on both upper and lower GI sensations. It runs from zero
to ten, with 1 being the detection threshold, 3 being a
definite moderate sensation, 5 the pain threshold, 7 mod-
erate pain, and 10 unbearable pain [19]. After clearing the
rectum with a suppository (Klyx, Ferring AS, Copenhagen,
Denmark), a multimodal rectal probe (Ditens A/S, Aalborg,
Denmark) was inserted through a small anoscope [20]. The
probe, measuring 6.2mm in diameter, had two channels
for circulating or filling water into a noncompliant 30𝜇m
thick polyester urethane balloon placed near the tip of the
probe. Two separate channels contained a thermometer and
a pressure sensor. Furthermore there were two electrodes
placed at the tip for electrical stimulations. Details of the
probe design have been described previously [20]. Rectal
thermal sensitivity was investigated by circulating 68∘Cwater
inside the rectal bag prefilled with 60mL of 37∘C water, thus
enabling a gradually rising temperature. Accurate circula-
tion flow rate (150mL/minute) was ensured by a peristaltic
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pump (Ole Dich Instrument Makers, Hvidovre, Denmark).
The temperature and time of circulation needed to reach
sensations corresponding to 1, 3, 5, and 7 on the VAS were
recorded. At VAS = 7 the heated water was immediately
evacuated to minimize participant discomfort. Mechanical
sensitivity was tested after emptying the rectal bag completely
then infusing 37∘C water at a constant rate of 200mL/minute
into the rectal bag, using the same peristaltic pump as
for thermal stimulations.Three preconditioning stimulations
to pain detection threshold were performed to minimise
the effect of viscoelastic properties of the rectum to the
mechanical distensions [20]. During the fourth stimulation
the actual sensory assessment was performed, and time of
filling and bag pressure needed to reach 1, 3, 5, and 7 on
the VAS were recorded. When patients reached the sensation
corresponding to 7 on the VAS, the pump was reversed and
the bag was emptied at the same rate. Time of emptying
from VAS 7 to VAS 0 was also recorded. Although the study
was not principally designed to examine the rectal biome-
chanical properties, the rectal compliance was estimated
according to a method previously described [21]. Electrical
sensitivity assessment commenced after ensuring adequate
mucous membrane contact by measuring the interelectrode
impedance (ideally ≤ 2 kΩ). In case of higher impedance,
the probe was gently manipulated and the electrical contact
reassessed. The electrical stimuli were administered as 2ms
square pulses via a computer-controlled constant current
stimulator (DIGITIMER Ltd., Welwyn Garden City, UK),
starting at subdetection levels and increasing in increments of
1mA. Intermittently, sham stimuli or a lower current intensity
was administered, in order to limit the effect of anticipation
and expectation. Participants were asked to report when
the rectal sensation reached 1, 3, 5, and 7 on the VAS,
and the corresponding current intensities were recorded.
This multimodal sensory assessment of the rectum has been
validated and described in greater detail elsewhere [20].
2.4. Heart Rate Variability. For evaluation of the heart rate
variability—a measure of the cardiac autonomic nervous
system—a 24 hour Holter ECG recording was performed in
all participants (Schiller MT-200, Schiller AG, Baar, Switzer-
land). The following time-domain parameters where calcu-
lated: (1) RR intervals (representing the average heart rate),
(2) standard deviation of normalized RR intervals (SDNN—
representing the total variability), (3) standard deviation of
5-minute segments of normalized RR intervals (SDANN),
(4) root mean square of the differences between successive
normalized RR intervals (RMSSD—primarily representing
the parasympathetic activity), and (5) the percentage of
normalized RR intervals that differ more than 50% compared
to the previous ones (pNN50—representing the parasympa-
thetic dominance over the sympathetic activity) [22].
2.5. Questionnaires. All participants completed two ques-
tionnaires. To evaluate GI symptoms, we used the Patient
Assessment of Upper Gastrointestinal Disorder Severity
Symptom Index (PAGI-SYM). It consists of 20 questions,
and symptoms in the preceding two weeks are graded
from 0 (no symptoms) to 5 (very severe symptoms). In
addition to a total score, six subscales were calculated:
postprandial fullness/early satiety, nausea/vomiting, bloat-
ing, upper abdominal pain, lower abdominal pain, and
heartburn/regurgitation [23]. Furthermore, the Short Form-
36 (SF-36) was employed to investigate health-related quality
of life. Both questionnaires have been previously translated,
validated, and extensively used in Norwegian.
2.6. Statistics. Statistical analyses were performed in Sigma-
Plot 11 (Systat Software Inc., San Jose, CA, USA), using a 𝑃
value of ≤0.05 as significance level. Results are given asmeans
± standard error of mean or if not normally distributed as
median (interquartile (IQ) range) unless otherwise specified.
To compare overall rectal sensitivities, a two-way analysis
of variance (ANOVA) was employed with the factors pain
modality and VAS level. When comparing the patients and
healthy controls in terms of baseline characteristics, gastric
emptying rate, heart rate variability, and questionnaires, one-
way ANOVAs were performed. Data that were not nor-
mally distributed were compared by Kruskal-Wallis’ method.
Correlations between rectal sensitivity, gastric emptying, GI
symptoms, and heart rate parameters were investigated by
Spearman’s rank order test.
3. Results
3.1. Gastric Emptying Rates. Radiopaque marker (ROM)
examination was performed in all patients and was positive
for gastroparesis in 60% (12 out of 20). The mean 4–6 hour
ROM retention rate in women (56.4 ± 9.5%) was numerically
higher than in men (40.4 ± 15.5%); however, this was not
statistically significant (𝑃 = 0.41).
3.2. Rectosigmoid Sensitivity and Compliance. All partici-
pants were successfully clamped, and themean blood glucose
levels were similar during testing (patients 6.4 ± 0.12 and
controls 6.1 ± 0.13mmol/L, 𝑃 = 0.12). Rectal sensitivities
are summarized in Figures 1(a)–1(c). In short, diabetes
patients needed significantly higher temperatures to induce
the various VAS-levels compared to controls; all VAS-levels
average temperature was 49.2 ± 0.80∘C in patients and 45.0 ±
0.88
∘C in healthy controls (𝐹 = 12.8, 𝑃 < 0.001). Similarly,
the duration of thermal stimulation was longer in patients
than in controls (74.4±5.3 seconds versus 44.6±5.7,𝐹 = 14.8,
𝑃 < 0.001). For mechanical sensitivity there were similar
results; at all VAS-levels average rectal balloon volume was
215 ± 13mL in patients and 151 ± 13mL in healthy controls
(𝐹 = 11.9, 𝑃 < 0.001). This corresponded to higher mean
rectal balloon pressure at the various VAS levels in the patient
cohort (22.3±1.7 cmH
2
O) than in the control cohort (15.4±
1.7 cm H
2
O, 𝐹 = 8.0, 𝑃 = 0.005). However, there was no
difference in compliance between patients (median 0.024
(0.020–0.048)mL/cm H
2
O) and controls (median 0.029
(0.023–0.062)mL/cm H
2
O), 𝑃 = 0.38.
The diabetes patients were also hyposensitive to elec-
trical stimulation and needed significantly higher current
intensities to reach the predefined VAS levels. All VAS levels
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Figure 1: (a) The rectal sensitivity to thermal stimulation. Patients showed overall hyposensitivity to heat (𝐹 = 12.8, 𝑃 < 0.001). The 𝑌-
axis describes the actual balloon temperature needed to induce the sensation corresponding to VAS ratings. Error bars represent SEM. (b)
The rectal sensitivity to mechanical stimulation. Patients showed overall hyposensitivity to mechanical distension (𝐹 = 11.9, 𝑃 < 0.001).
The 𝑌-axis describes the rectal balloon volumes needed to induce the corresponding VAS ratings. Error bars represent SEM. (c) The rectal
sensitivity to electrical stimulation. Patients showed overall hyposensitivity to electrical stimulation (𝐹 = 8.8,𝑃 < 0.004).The𝑌-axis describes
the current intensity needed to induce the corresponding VAS scores. Error bars represent SEM.
average current intensity was 26.0 ± 1.5mA in patients and
19.6 ± 1.7mA in healthy controls (𝐹 = 8.8, 𝑃 < 0.004). In
relative terms, diabetes patients needed 67% and 42% more
time of thermal andmechanical stimulations, and 33%higher
electrical current intensities to reach the same VAS levels as
the healthy controls.
3.3. Heart Rate Variability. Technically acceptable 24-hour
Holter results were obtained in 18 patients and 11 healthy
volunteers. The heart rate was higher in patients (mean RR
interval in patients 745 ± 106ms compared to 820 ± 79ms
in healthy controls, 𝑃 = 0.05). Also, most parameters of
heart rate variability were reduced in patients: median SDNN
102ms (interquartile range 71–118) versus 137ms (118–168),
𝑃 = 0.02; median SDANN 83ms (60–96) versus 128ms (98–
141) 𝑃 = 0.004. Median pNN50 was reduced in patients 2.5%
(1.1–6.0) versus 13.0% (3.0–24.4) in healthy controls,𝑃 = 0.02.
There was no difference between the two groups in terms of
RMSSD, in patients 28ms (17–46) and in controls 38ms (23–
52), 𝑃 = 0.29.
3.4. Questionnaires. The patients scored significantly higher
in all of the investigated aspects of upper and lower gas-
trointestinal symptoms (all 𝑃 < 0.001); see Table 2. The SF-
36 questionnaire revealed a strongly reduced self-reported
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Table 2: PAGI-SYM scores.
Patients Healthy controls
Subscale
item
Postprandial
fullness 3.50 (2.75–4.0) 0.25 (0.0–0.44)
Nausea/vomiting 1.33 (0.50–3.25) 0.0 (0.0-0.0)
Bloating 3.50 (3.50–4.75) 0.0 (0.0-0.0)
Upper abd. pain 2.76 (±0.40) 0.10 (±0.07)
Lower abd. pain 2.00 (1.00–3.50) 0.0 (0.0-0.0)
Heartburn/regurg. 1.14 (0.86–2.61) 0.0 (0.0-0.0)
Total score 2.25 (1.54–2.91) 0.05 (0.0–0.23)
Results of the patient assessment of upper gastrointestinal disorder severity
symptom index (PAGI-SYM) questionnaire. Twenty patients and 15 healthy
controls completed the questionnaire. Abd. = abdominal, regurg. = regurgi-
tation. All 𝑃 < 0.001.
health in the patient cohort with all SF-36 subscales reduced
(all 𝑃 < 0.05). For details, please see Table 3.
3.5. Clinical Correlations. According to our hypothesis, we
investigated the associations between rectal sensitivity, gas-
tric emptying, heart rate parameters, and gastrointestinal
symptoms.There were no statistically significant correlations
between rectosigmoid sensitivity and gastrointestinal symp-
toms (PAGI-SYM). The gastric retention rate was positively
associated with the temperature sensitivity (𝑟 = 0.59, 𝑃 =
0.02); that is, themore delayed the gastric emptying, themore
increased the rectal sensitivity to temperature. There was a
similar trend in mechanical pressure, but it did not reach
statistical significance (𝑟 = 0.44, 𝑃 = 0.08). Gastric retention
was also negatively associated with symptoms of nausea and
vomiting (𝑟 = −0.51, 𝑃 = 0.03); that is, the more delayed the
gastric emptying, the less the symptoms.The RR interval was
negatively associated with symptoms of postprandial fullness
(𝑟 = −0.49, 𝑃 = 0.04) as well as the rectal temperature sensi-
tivity (𝑟 = −0.63,𝑃 = 0.01); that is, patients with highermean
heart rate had more symptoms of fullness and reduced rectal
sensitivity to heat. No other associations could be detected
between these predefined parameters.
4. Discussion
We have shown that patients with symptoms and signs of
diabetic gastroparesis had sensory deficits in the distal gas-
trointestinal tract, indicating a widespread nature of visceral
neuropathy. Furthermore, patients had reduced heart rate
variability and increased mean heart rate, a sign of extensive
autonomic dysfunction in DM. Differences in rectosigmoid
compliance between DM patients and controls were not
detected.
Major limitations include the relatively low number of
study subjects and the mixed type 1 and type 2 DM cohort.
Although the two conditions share some specific patho-
genetic traits (in particular hyperglycemia), the symptom
presentation and gastric emptying rate may differ slightly.
Type 1 DM patients have been shown to be more prone
to vomiting, whereas type 2 patients have relatively more
Table 3: SF-36 scores.
Patients Healthy controls
Subscale
item
Physical
functioning 72.5 (40.0−85.0) 100.0 (100.0-100.0)
Role lim. phys.
(RP) 0.0 (0.0−50.0) 100.0 (100.0-100.0)
Bodily pain 41.6 (±26.6) 88.5 (±12.6)
General health 33.4 (±19.8) 85.2 (±16.6)
Energy
fatigue/vitality 32.5 (±18.4) 75.7 (±13.7)
Social
functioning 62.5 (37.5−75.0) 100.0 (100.0-100.0)
Role lim. emot.
(RE) 100.0 (33.3−100.0) 100.0 (100.0-100.0)
Mental health
(MH) 76.0 (68.0−80.0) 84.0 (76.0−92.0)
Summary
scores
Physical comp.
(PCS) 33.3 (18.8−39.2) 55.8 (54.0−57.3)
Mental com.
(MCS) 47.7 (42.9−50.0) 53.1 (48.5−55.3)
Results of the Short Form-36 questionnaire, presented as median (IQ-range)
or mean (±SD). Eighteen patients and 15 healthy controls completed the
questionnaire. RP = role limitations due to physical health, RE = role
limitations due to emotional problems, PCS = physical component summary
and MCS = mental component summary.
All 𝑃 < 0.001 except RE: 𝑃 = 0.02, MH: 𝑃 = 0.04, and MCS: 𝑃 = 0.02.
nausea. On average, gastric retention is more pronounced in
type 1 DM, although the differences are subtle [24]. Method
specific limitations are discussed below.
Unlike the colon, the rectum receives innervation from
both visceral (sacral) and somatic (pudendal) nerves. In
this study we wanted to investigate the visceral afferents
specifically, and the probe was positioned at least 15 cm
above the anus, thus limiting involvement of the lower
somatic nerve afferents. Although rectal sensations by nature
primarily deal with the feeling of fullness and the urge to
defecate, we chose a multimodal approach in order to obtain
a comprehensive sensory profile. Thermal stimulation has
the advantage of being highly reproducible. It stimulates
the mucosal receptors directly, although it is probably less
physiological in nature. Mechanical stimulation, on the other
hand, is more physiological but also depends on the varying
elastic properties of the rectum, the muscular tone, and
neuromuscular feedback loops. Finally, electrical stimulation
is highly reproducible; it bypasses the peripheral receptors
entirely and depolarizes the nerve endings directly [20, 25].
Gut sensitivity andmotility are subject tomodification by
glucose and insulin levels. Both act as sensitizers to stretch
in the stomach [26]. Our previous studies indicate a role
for insulin, but not glucose, in the sensitivity to electrical
stimulation in the esophagus [18, 27]. The anorectal region
is less well investigated in this respect, and results are some-
what contradictory (increased, decreased, or no effect of
hyperglycemia on sensitivity) [28–30]. To avoid any inter-
ference, we decided to use a hyperinsulinemic euglycemic
clamp technique in all study subjects. This setup combined
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with multimodal rectal sensory assessment has been used in
several previous studies and yields reproducible and phys-
iologically meaningful results [4, 15]. In this study, no dif-
ference between diabetes patients and controls could be
detected in terms of the rectosigmoid compliance; that is, the
mechanosensory findings were likely unrelated to changes
in rectal wall properties. Some previous studies have found
reduced rectal compliance inDM, but this seems to have been
strongly influenced by the actual blood glucose levels [16, 28].
In our study, euglycemia was ensured by a hyperinsulinemic
clamp technique, possibly influencing our findings.
Reduced sensitivity in diabetes patients is not necessarily
the product of peripheral nerve pathology. Altered structure
and/or activity at central nervous system levels are undoubt-
edly present in patients with both somatic and autonomic
neuropathies, as has been demonstrated by severalMRI stud-
ies [7, 31–33]. Furthermore, electrophysiological studies using
evoked potentials with advanced brain activitymodeling have
also detected abnormal brain activity patterns in patients
with diabetes, autonomic neuropathy, and gastrointestinal
symptoms [4, 34]. Indeed, a subset of subjects included in
this study has previously been investigated using electrically
induced evoked brain potentials, where functional brain
changes could be detected [5]. Still, at least some degree
of peripheral pathology can be argued for, as the degree of
hyposensitivity varies according to the mode of stimulation;
that is, the least hyposensitivity was detected in the case
of electrical stimulation—bypassing the mucosal receptors,
possibly indicating a noncentral involvement.
This study demonstrated that diabetes patients with
symptoms of upper GI dysfunction have a widespread vis-
ceral hyposensitivity. Thus, it is plausible—although not
yet proven—that DM affects nerves in the entire GI tract.
Although clearly multifactorial, diabetic autonomic neuro-
pathy—in particular affecting the vagal nerve—has been
implicated in upperGI dysfunction.The afferent visceral sen-
sory nerves innervating the lower GI tract travel a relatively
short distance through the pelvic splanchnic nerves to the
sacral parts of the spinal cord. Thus, these two visceral nerve
pathways are distinct in terms of localization, length, and
distribution. Our results suggest that nervous dysfunction in
DM is not limited to thewell-investigated vagal nerve butmay
also include the shorter splanchnic nerves. This implicates
that small fiber diabetic neuropathy possibly is less length-
dependent than large-fiber sensorimotor polyneuropathies.
This, in turn, might help explain the varied clinical presenta-
tions of visceral complications in DM [35]. From a clinicians’
perspective, diverse neuropathic complications should be
actively considered, once a patient presents symptoms of
autonomic dysfunction in any organ system.
In this explorative study, we only investigated the associ-
ations in line with our hypothesis. Gastric retention showed
positive association with rectal sensitivity and negative asso-
ciation with the feeling of gastric fullness. That is, the more
delayed the gastric emptying, the less the symptoms and the
higher the rectal sensitivity to heat. Although somewhat sur-
prising, our results are in line with a number of studies which
have found very weak—if any—correlation between gastric
emptying rates and symptoms of diabetic gastroparesis [36,
37]. Indeed, there is an ongoing controversy surrounding
the relationship between these parameters, which strongly
affects clinical intervention trials [38, 39]. Finally, themethod
of investigating gastric emptying—by radiopaque markers—
may be less sensitive and show moderate correlation to the
gold standard, scintigraphy, although the latter has shown
similar poor association to upper gastrointestinal symptoms
[11, 40]. Among heart rate parameters, the RR interval was
associated with visceral sensitivity, that is, reduced thermal
sensitivity with increasing heart rate. Increased mean heart
rate is a well-known early marker of cardiac autonomic neu-
ropathy, so any association with visceral sensitivity is in line
with a pathophysiological explanation involving autonomic
neuropathy [35]. A limitation of the present study in this
respect is the lack of spectral frequency analysis—a method
whichmight detectmore subtle cardiac autonomic imbalance
[41].
Diabetic gastrointestinal complications are challenging to
investigate and diagnose. This is partly not only due to the
inaccessibility of GI organs but also due to the imprecise
nature of GI motility measurements and the poor corre-
lation between symptoms, GI dysmotility, and autonomic
neuropathy [42, 43]. Also, GI symptoms are so common in
general that the clinical question of diabetic GI complica-
tions frequently arises. The invasive sensory investigations
performed by our group in this and previous studies have
demonstrated a concomitant affection of upper and lower GI
tract, in conjunction with cardiac autonomic dysfunction [5].
Investigating the heart rate variability through electrocardio-
graphy or other parameters of cardiac autonomic function
is easy and hazard-free for the patient. Due to multiple
weak associations between various autonomic dysfunctions,
these investigations are not likely to offer meaningful positive
predictive information as far as diabetic gut dysfunctions are
concerned. On the other hand, normal cardiac autonomic
function might indicate that the GI signs and symptoms
are not caused by autonomic dysfunction. This would make
heart-rate variability testing a logical first step to screen
diabetic from nondiabetic GI complaints. Further studies are
warranted to test this hypothesis.
In conclusion, this study provided evidence of the gen-
eralized nature of diabetic autonomic neuropathy. Diabetes
patients with signs and symptoms of upper GI dysfunction
displayed reduced rectal sensitivity to heat and mechanical
and electrical stimulation. Also, the heart rate variability was
impaired. In a clinical setting, the presence of autonomic
dysfunction could be regarded as a diffuse neuropathic
complication.
Abbreviations
ANOVA: Analysis of variance
BMI: Body mass index
DM: Diabetes mellitus
ECG: Electrocardiography
GI: Gastrointestinal
IQ-range: Interquartile range
MRI: Magnetic resonance imaging
Journal of Diabetes Research 7
PAGI-SYM: Patient assessment of upper gastrointestinal
disorder severity symptom index
ROM: Radiopaque marker
SEM: Standard error of the mean
SD: Standard deviation
SF-36: Short Form-36
VAS: Visual analogue scale.
Conflict of Interests
The authors declare that they have no conflict of interests.
Authors’ Contribution
Christina Brock, Magnus Simre´n, Jens B. Frøkjær, and
Asbjørn M. Drewes participated in study design; Eirik
Søfteland, Christina Brock, Jens B. Frøkjær, and Georg
Dimcevski participated in data collection; Eirik Søfteland,
Christina Brock, and Georg Dimcevski participated in data
analysis; all coauthors participated in interpretation of results;
Eirik Søfteland and Georg Dimcevski participated in paper
preparation. All coauthors participated in critical revision of
paper. Eirik Søfteland is the guarantor of this work and, as
such, had full access to all the data in the study and takes
responsibility for the integrity of the data and the accuracy
of the data analysis.
Acknowledgments
The authors would like to acknowledge the invaluable assis-
tance of the Clinical Research Unit at Haukeland University
Hospital. The research leading to these results has received
funding from the European Community’s Seventh Frame-
work Programme FP7/2007–2013 under Grant Agreement
no. 223630 and from the Norwegian Diabetes Association.
References
[1] P. Bytzer,N. J. Talley,M. Leemon, L. J. Young,M. P. Jones, andM.
Horowitz, “Prevalence of gastrointestinal symptoms associated
with diabetes mellitus: A population-based survey of 15000
adults,” Archives of Internal Medicine, vol. 161, no. 21, pp. 1989–
1996, 2001.
[2] G. T. C. Ko,W.-B. Chan, J. C. N. Chan, L.W.W. Tsang, and C. S.
Cockram, “Gastrointestinal symptoms in Chinese patients with
type 2 diabetes mellitus,” Diabetic Medicine, vol. 16, no. 8, pp.
670–674, 1999.
[3] M. Camilleri, H. P. Parkman, M. A. Shafi, T. L. Abell, and L.
Gerson, “Clinical guideline: management of gastroparesis,”The
American Journal of Gastroenterology, vol. 108, no. 1, pp. 18–37,
2013.
[4] D. Lelic, C. Brock, E. Søfteland et al., “Brain networks encoding
rectal sensation in type 1 diabetes,” Neuroscience, vol. 237, pp.
96–105, 2013.
[5] C. Brock, E. Softeland,V.Gunterberg et al., “Diabetic autonomic
neuropathy affects symptom generation and brain-gut axis,”
Diabetes Care, vol. 36, pp. 3698–3705, 2013.
[6] D. Selvarajah, I. D. Wilkinson, J. Davies, R. Gandhi, and
S. Tesfaye, “Central nervous system involvement in diabetic
neuropathy,”CurrentDiabetes Reports, vol. 11, no. 4, pp. 310–322,
2011.
[7] J. B. Frøkjaer, L. W. Andersen, C. Brock et al., “Altered brain
microstructureassessedby diffusion tensor imaging in patients
with diabetes and gastrointestinal symptoms,” Diabetes Care,
vol. 36, no. 3, pp. 662–668, 2013.
[8] B. Krishnan, S. Babu, J. Walker, A. B. Walker, and J. M. Pap-
pachan, “Gastrointestinal complications of diabetes mellitus,”
World Journal of Diabetes, vol. 4, pp. 51–63, 2013.
[9] P. D. Hardt and N. Ewald, “Exocrine pancreatic insufficiency
in diabetes mellitus: a complication of diabetic neuropathy or
a different type of diabetes?” Experimental Diabetes Research,
vol. 2011, Article ID 761950, 7 pages, 2011.
[10] S. de Kort, J. W. Kruimel, J. P. Sels, I. C. W. Arts, N. C. Schaper,
and A. A. M. Masclee, “Gastrointestinal symptoms in diabetes
mellitus, and their relation to anxiety and depression,” Diabetes
Research and Clinical Practice, vol. 96, no. 2, pp. 248–255, 2012.
[11] E. A. Olausson, C. Brock, A. M. Drewes et al., “Measurement of
gastric emptying by radiopaque markers in patients with dia-
betes: correlation with scintigraphy and upper gastrointestinal
symptoms,” Neurogastroenterology and Motility, vol. 25, no. 3,
pp. e224–e232, 2013.
[12] Y. Ron, A. D. Sperber, A. Levine et al., “Early satiety is the
only patient-reported symptom associated with delayed gastric
emptying, as assessed by breath-test,” Journal of Neurogastroen-
terology and Motility, vol. 17, no. 1, pp. 61–66, 2011.
[13] H. P. Parkman, K. Yates, W. L. Hasler et al., “Clinical features
of idiopathic gastroparesis vary with sex, body mass, symptom
onset, delay in gastric emptying, and gastroparesis severity,”
Gastroenterology, vol. 140, no. 1, pp. 101–115, 2011.
[14] W. L. Hasler, L. A. Wilson, H. P. Parkman et al., “Factors related
to abdominal pain in gastroparesis: contrast to patients with
predominant nausea and vomiting,” Neurogastroenterology and
Motility, vol. 25, no. 5, pp. 427–e301, 2013.
[15] E. Softeland, C. Brock, J. B. Frokjaer et al., “Association between
visceral , cardiac and sensorimotor polyneuropathies in dia-
betes mellitus,” Journal of Diabetes and its Complications, vol.
28, pp. 370–377, 2014.
[16] W.M. Sun, P. Katsinelos,M.Horowitz, andN.W. Read, “Distur-
bances in anorectal function in patients with diabetes mellitus
and faecal incontinence,” European Journal of Gastroenterology
and Hepatology, vol. 8, no. 10, pp. 1007–1012, 1996.
[17] B. J. Caruana, A. Wald, J. P. Hinds, and B. H. Eidelman,
“Anorectal sensory and motor function in neurogenic fecal
incontinence: comparison between multiple sclerosis and dia-
betes mellitus,” Gastroenterology, vol. 100, no. 2, pp. 465–470,
1991.
[18] E. Søfteland, G. Dimcevski, C. Graversen, B. G. Nedreb, A. M.
Drewes, and J. B. Frkjr, “Effects of isolated hyperinsulinaemia on
sensory function in healthy adults,” Experimental and Clinical
Endocrinology and Diabetes, vol. 119, no. 10, pp. 604–609, 2011.
[19] A. M. Drewes, G. Dimcevski, S. A. K. Sami et al., “The “human
visceral homunculus” to pain evoked in the oesophagus,
stomach, duodenum and sigmoid colon,” Experimental Brain
Research, vol. 174, no. 3, pp. 443–452, 2006.
[20] C. Brock, T. D. Nissen, F. H. Gravesen et al., “Multimodal
sensory testing of the rectum and rectosigmoid: development
and reproducibility of a new method,” Neurogastroenterology
and Motility, vol. 20, no. 8, pp. 908–918, 2008.
[21] H. Gregersen, Biomechanics of the Gastrointestinal Tract: New
Perspectives in Motility Research and Diagnostics, 2003.
8 Journal of Diabetes Research
[22] L. Bernardi, V. Spallone, and M. Stevens, “Investigation meth-
ods for cardiac autonomic function in human research studies,”
Diabetes/Metabolism Research and Reviews, 2011.
[23] A. M. Rentz, P. Kahrilas, V. Stanghellini et al., “Development
and psychometric evaluation of the patient assessment of
upper gastrointestinal symptom severity index (PAGI-SYM) in
patients with upper gastrointestinal disorders,” Quality of Life
Research, vol. 13, no. 10, pp. 1737–1749, 2004.
[24] H. P. Parkman, K. Yates, W. L. Hasler et al., “Similarities
and differences between diabetic and idiopathic gastroparesis,”
Clinical Gastroenterology and Hepatology, vol. 9, no. 12, pp.
1056–1064, 2011.
[25] R. E. Burgell and S. M. Scott, “Rectal hyposensitivity,” Journal of
Neurogastroenterology and Motility, vol. 18, no. 4, pp. 373–384,
2012.
[26] G. S. Hebbard, W. M. Sun, J. Dent, and M. Horowitz, “Hyper-
glycaemia affects proximal gastric motor and sensory function
in normal subjects,” European Journal of Gastroenterology and
Hepatology, vol. 8, no. 3, pp. 211–217, 1996.
[27] J. B. Frøkjær, E. Søfteland, C. Graversen, G. Dimcevski, and A.
M. Drewes, “Effect of acute hyperglycaemia on sensory pro-
cessing in diabetic autonomic neuropathy,” European Journal of
Clinical Investigation, vol. 40, no. 10, pp. 883–886, 2010.
[28] A. Russo, R. Botten, M.-. Kong et al., “Effects of acute hyper-
glycaemia on anorectal motor and sensory function in diabetes
mellitus,” Diabetic Medicine, vol. 21, no. 2, pp. 176–182, 2004.
[29] A. Russo, W. M. Sun, Y. Sattawatthamrong et al., “Acute
hyperglycaemia affects anorectal motor and sensory function
in normal subjects,” Gut, vol. 41, no. 4, pp. 494–499, 1997.
[30] A. C. Hernando-Harder, M. V. Singer, and H. Harder, “Effect of
duodenal glucose and acute hyperglycemia on rectal perception
and compliance in response to tension-controlled rectal disten-
sion in healthy humans,”Digestive Diseases and Sciences, vol. 53,
no. 6, pp. 1624–1631, 2008.
[31] I. D. Wilkinson, D. Selvarajah, M. Greig et al., “Magnetic
resonance imaging of the central nervous system in diabetic
neuropathy,” Current Diabetes Reports, vol. 13, no. 4, pp. 509–
516, 2013.
[32] J. B. Frokjaer, C. Brock, E. Softeland et al., “Macrostructural
brain changes in patients with longstanding type 1 diabetes
mellitus: a cortical thickness analysis study,” Experimental and
Clinical Endocrinology and Diabetes, vol. 121, no. 6, pp. 354–360,
2013.
[33] D. Selvarajah, I. D. Wilkinson, C. J. Emery et al., “Thalamic
neuronal dysfunction and chronic sensorimotor distal symmet-
rical polyneuropathy in patients with type 1 diabetes mellitus,”
Diabetologia, vol. 51, no. 11, pp. 2088–2092, 2008.
[34] G. Comi, “Evoked potentials in diabetes mellitus,” Clinical
Neuroscience, vol. 4, no. 6, pp. 374–379, 1997.
[35] A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman,
“Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5,
pp. 1553–1579, 2003.
[36] S. S. Thazhath, K. L. Jones, M. Horowitz, and C. K. Rayner,
“Diabetic gastroparesis: recent insights into pathophysiology
and implications for management,” Expert Review of Gastroen-
terology & Hepatology, vol. 7, no. 2, pp. 127–139, 2013.
[37] N. J. Talley, M. Verlinden, and M. Jones, “Can symptoms
discriminate among those with delayed or normal gastric
emptying in dysmotility-like dyspepsia?”TheAmerican Journal
of Gastroenterology, vol. 96, no. 5, pp. 1422–1428, 2001.
[38] P. Janssen, M. S. Harris, and M. Jones, “The relation between
symptom improvement and gastric emptying in the treatment
of diabetic and idiopathic gastroparesis,”The American Journal
of Gastroenterology, vol. 108, no. 9, pp. 1382–1391, 2013.
[39] R. W. Mccallum, A. Lembo, T. Esfandyari et al., “Phase 2b,
randomized, double-blind 12-week studies of TZP-102, a ghrelin
receptor agonist for diabetic gastroparesis,”Neurogastroenterol-
ogy and Motility, vol. 25, no. 11, pp. e705–e717, 2013.
[40] A. J. Bredenoord, H. J. Chial, M. Camilleri, B. P. Mullan,
and J. A. Murray, “Gastric accommodation and emptying in
evaluation of patients with upper gastrointestinal symptoms,”
Clinical Gastroenterology and Hepatology, vol. 1, no. 4, pp. 264–
272, 2003.
[41] M. Scho¨nauer, A. Thomas, S. Morbach, J. Niebauer, U. Scho¨-
nauer, and H.Thiele, “Cardiac autonomic diabetic neuropathy,”
Diabetes and Vascular Disease Research, vol. 5, no. 4, pp. 336–
344, 2008.
[42] A. S. Shin andM. Camilleri, “Diagnostic assessment of diabetic
gastroparesis,” Diabetes, vol. 62, pp. 2667–2673, 2013.
[43] J. E. Stevens, K. L. Jones, C. K. Rayner, andM.Horowitz, “Patho-
physiology and pharmacotherapy of gastroparesis: current and
future perspectives,” Expert Opinion on Pharmacotherapy, vol.
14, no. 9, pp. 1171–1186, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
